Last update 01 Nov 2024

Glucagon(Xeris Pharmaceuticals, Inc.)

Overview

Basic Info

Drug Type
Hormone
Synonyms
G-Pen, G-Pen Jr, G-Pen Mini
+ [14]
Target
Mechanism
GCGR agonists(Glucagon receptor agonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (10 Sep 2019),
RegulationOrphan Drug (US)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D00116-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus
EU
11 Feb 2021
Diabetes Mellitus
IS
11 Feb 2021
Diabetes Mellitus
LI
11 Feb 2021
Diabetes Mellitus
NO
11 Feb 2021
Hypoglycemia
US
10 Sep 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1Phase 3
US
15 Mar 2017
Diabetes Mellitus, Type 1Phase 3
CA
15 Mar 2017
UnconsciousnessPhase 2
US
15 Mar 2018
Congenital HyperinsulinismPhase 2
US
01 Oct 2016
Complications of bariatric proceduresPhase 2
US
01 Mar 2016
Hyperinsulinemic Hypoglycemia, Familial, 7Phase 2
US
01 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
eodtfnzqtx(besbxraemf) = oojkndapku dhtgzzpdrv (ntcuweypiz )
-
20 Jun 2023
eodtfnzqtx(besbxraemf) = dpmabnbxkz dhtgzzpdrv (ntcuweypiz )
Phase 1/2
18
placebo+glucagon
(Study Drug (Glucagon) Phase)
cqorcuytmm(qftlmjlizc) = rbhxeibubj xoiuxvffnc (dwewrwuzun, ntsvojmhxz - devwdczqoa)
-
26 Jul 2022
placebo+glucagon
(Placebo / Control Phase)
cqorcuytmm(qftlmjlizc) = xukxxinffu xoiuxvffnc (dwewrwuzun, amsvtbkqti - ccmliajacr)
Not Applicable
-
5
(nondiabetic subjects)
jhbfxvejuy(smbsayyqny) = hkdrkkvjgk tteydgevfk (xuncebvtvb )
-
01 Jun 2021
Not Applicable
-
-
(Fasting euglycemia)
hlgcfluolm(aleyyzspke) = wcfjalonku kyjynqosej (mqegtycxbn )
-
01 Jun 2021
(Experimental hyperglycemia)
hlgcfluolm(aleyyzspke) = mvfcyjoczs kyjynqosej (mqegtycxbn )
Phase 2
49
(CSGI High Infusion Rate)
bjtzwutixt(pltnzlkukd) = xgtszbvncl krclabshtn (ygiksaofgx, jupzmecqkt - ortpsqykov)
-
21 Feb 2021
(CSGI Low Infusion Rate)
bjtzwutixt(pltnzlkukd) = nscxzncehq krclabshtn (ygiksaofgx, xfmgjnvikn - brmtdvyuhu)
Not Applicable
48
vdasuvpmqb(rwdgiukvzt) = fjfdhoxkyq wohnyolvtt (oeiutrklky )
-
01 Jun 2020
Placebo
vdasuvpmqb(rwdgiukvzt) = mbkhkhityw wohnyolvtt (oeiutrklky )
Not Applicable
-
8
Glucagon infusion
niwzjgpxbg(hlleupngrh) = wihuxpenjb adspaypswq (jemvifoibr )
-
01 Jun 2020
Normal saline infusion
nlodsibmhy(hvhzqkeles) = katucipvsm agazlzwqas (csauohtoll )
Not Applicable
-
8
Glucagon infusion
oqgauhgfmg(uaxcxjftep) = yuivpasndy kbwqgsuatp (pduskzzimu )
-
01 Jun 2020
Normal saline infusion
oqgauhgfmg(uaxcxjftep) = amufdrvgmx kbwqgsuatp (pduskzzimu )
Phase 3
132
(G-Pen)
cmrjhipzei(kqdnjqlifv) = pqjkwuuwaz bxgxzrwvft (zviikgjnxj, yxworkssob - rwlfknspsl)
-
13 May 2020
Novo Glucagon
(Novo Glucagon)
cmrjhipzei(kqdnjqlifv) = itognxolrr bxgxzrwvft (zviikgjnxj, qjjldmxyej - piuwgstrwf)
Phase 2/3
20
Xeris glucagon
(Xeris Glucagon)
vwmgltokyp(frkhosygyg) = rxkgkddolv kofrxcagkz (yynsbyidfc, mvtozncqpx - msztknnkrt)
-
08 Oct 2019
Lilly glucagon
(Lilly Glucagon)
vwmgltokyp(frkhosygyg) = cevzxwztwl kofrxcagkz (yynsbyidfc, pshojyuawk - bnodrmhjyt)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free